The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
📩 Subscribe
// STATE LEGISLATION TRACKER

Florida SB 542: Naturopathy

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed
State
Florida
Bill
SB 542
Session
2026
Filed
2025-11-18
Read the bill
OpenStates →
Last reviewed
2026-10-02

Plain-English Summary

SB542 would have reestablished and regulated naturopath licensing in Florida through a new Board of Naturopathy. For peptide users, its relevance is limited: it does not appear to address compounded peptides, FDA 503A/503B compounding, telehealth, NP scope, or prescription monitoring, and it died in committee.

Key Points

  • No direct change to peptide access because the bill failed
  • Would have created a regulated path for Florida naturopaths
  • Does not appear to expand NP or telehealth peptide prescribing
  • Does not address 503A or 503B peptide compounding
  • Controlled substances were listed outside naturopath scope

What to Watch For

i
Note Similar naturopath licensing bills could return in later Florida sessions.
✓
Opportunity A future version could expand regulated clinician options for patients using integrative care.
!
Concern If revived, scope limits could still leave most prescription peptides outside naturopath authority.

Where the Bill Stands

The bill died in the Senate Health Policy Committee on March 13, 2026, so it did not become law.
· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.
Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws